title: [Successful treatment of Bowen disease with ingenol mebutate].
abstract: Ingenol mebutate is a novel cytotoxic drug extracted from the plant Euphorbia peplus. Since November 2012 it is approved in Germany for the treatment of superficial actinic keratoses. We report the successful treatment of Bowen disease with ingenol mebutate in a patient being treated with the multikinase inhibitor sunitinib for to metastatic clear cell renal carcinoma.
authors.affiliation: Hautklinik des Universitätsklinikums Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Deutschland.
authors.forename: S A
authors.initials: SA
authors.lastname: Braun
authors.forename: B
authors.initials: B
authors.lastname: Homey
authors.forename: P A
authors.initials: PA
authors.lastname: Gerber
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage; D001913:Bowen's Disease / Q000188:drug therapy* / Q000473:pathology*; D004224:Diterpenes / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology*
chemical_list: C486592:3-ingenyl angelate; D000970:Antineoplastic Agents; D004224:Diterpenes